AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
MUMBAI, July 2 Asia Pulse - Drug major Glenmark Pharmaceuticals on Monday said it has received the United States Food and Drug Administration's (USFDA) tentative approval to market Topiramate tablets, used in the treatment of migraine.
The company has received a tentative approval from USFDA for its Abbreviated New Drug Application (ANDA), Topiramate tablets in multiple strengths of 25 mg, 50 mg, 100 mg and 200 mg, Glenmark informed the Bombay Stock Exchange (BSE).
The branded sales of Topiramate tablets, an anti-epileptic drug which falls in the ...
Source: HighBeam Research, INDIA'S GLENMARK GETS TENTATIVE USFDA NOD FOR TOPIRAMTE TABS.